Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The practical takeaway: AOD-9604 has a clean safety profile in trials but a failed Phase 2b efficacy endpoint
not approved Tirzepatide (Zepbound) Approved (Zepbound, Mounjaro) Semaglutide alone (Wegovy) Approved (Wegovy, Ozempic) Cagrilintide alone Investigational Feature Head-to-head data CagriSema Did not meet non-inferiority vs tirzepatide at 84 wks (Reuters Feb 2026) Tirzepatide (Zepbound) Semaglutide alone (Wegovy) Cagrilintide alone These compounds are not interchangeable
Affordable GLP-1 Weight Loss Telehealth Care for Every Patient in Florida and Beyond Call Today (954) 551-3508 Or Book Online Retatrutide Side Effects Reported in Trials Most side effects were mild to moderate : Nausea Vomiting Diarrhea Constipation Mild increases in heart rate These are consistent with the GLP-1 class of medications
After reconstituting a peptide with bacteriostatic water, the reconstituted peptide solution should be stored at 2-8C (refrigerator) and used within 28-30 days for optimal stability
Neyrinck AM, Van Hee VF, Piront N, De Backer F, Toussaint O, Cani PD, et al
[PMID: 42220603] PubMed record related to this compound for laboratory literature review
